COMPARED TO INSULIN GLARGINE, TIRZEPATIDE REDUCES THE PREVALENCE OF THE METABOLIC SYNDROME IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK: POST-HOC ANALYSIS OF SURPASS-4

被引：0
|
作者：
Nicholls, Stephen J. [1 ]
D'Alessio, David [1 ]
Wiese, Russell [1 ]
Pavo, Imre [1 ]
Zeytinoglu, Meltem [1 ]
Romera, Irene [1 ]
Weerakkody, Govinda J. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
910-10
引用
收藏
页码：1628 / 1628
页数：1
相关论文
共 50 条
  • [31] Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post-hoc analysis
    Aso, Yoshimasa
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (08) : 1316 - 1318
  • [32] Smoking and prevalence of nocturia in Japanese patients with type 2 diabetes mellitus: a post-hoc analysis of The Dogo Study
    Furukawa, Shinya
    Sakai, Takenori
    Niiya, Tetsuji
    Miyaoka, Hiroaki
    Miyake, Teruki
    Yamamoto, Shin
    Kanzaki, Sayaka
    Maruyama, Koutatsu
    Tanaka, Keiko
    Ueda, Teruhisa
    Senba, Hidenori
    Torisu, Masamoto
    Minami, Hisaka
    Onji, Morikazu
    Tanigawa, Takeshi
    Matsuura, Bunzo
    Hiasa, Yoichi
    Miyake, Yoshihiro
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (05) : 1336 - 1341
  • [33] Prevalence of the metabolic syndrome and associated novel cardiovascular risk factors in patients with Type 2 diabetes
    Bianchi, C
    Penno, G
    Giovannitti, MG
    Pucci, L
    Pellegrini, G
    Caricato, E
    Bertolotto, A
    Corfini, M
    Del Prato, S
    Miccoli, R
    DIABETOLOGIA, 2004, 47 : A124 - A125
  • [34] Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes Post hoc analysis of an open-label, randomised, phase 3 trial
    Schuerfeld, Robin
    DIABETOLOGIE, 2023, 19 (02): : 205 - 207
  • [35] Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes
    Orna, JAG
    Arnal, LML
    Herguedas, EM
    Julián, BB
    Córdoba, DPP
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (06): : 507 - 513
  • [36] Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study
    Manosroi, Worapaka
    Phimphilai, Mattabhorn
    Waisayanand, Nipawan
    Buranapin, Supawan
    Deerochanawong, Chaicharn
    Gunaparn, Siriluck
    Phrommintikul, Arintaya
    Wongcharoen, Wanwarang
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (12) : 1391 - 1400
  • [37] Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial
    Hankosky, Emily R.
    Wang, Hui
    Neff, Lisa M.
    Kan, Hong
    Wang, Fangyu
    Ahmad, Nadia N.
    Stefanski, Adam
    Garvey, W. Timothy
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3748 - 3756
  • [38] Post Hoc Analysis of SURPASS-1 to-5: Efficacy and Safety of Tirzepatide in Adults with Type 2 Diabetes are Independent of Baseline Characteristics
    De Block, Christophe
    Peleshok, Jennifer
    Wilding, John P. H.
    Kwan, Anita Y. M.
    Rasouli, Neda
    Maldonado, Juan M.
    Wysham, Carol
    Liu, Minzhi
    Aleppo, Grazia
    Benneyworth, Brian D.
    DIABETES THERAPY, 2025, 16 (01) : 43 - 71
  • [39] Prevalence of cardiovascular risk factors and metabolic syndrome in patients with type 2 diabetes mellitus in cardiac rehab
    Blanc, Philippe
    Boussuges, Alain
    Maunier, Sebastien
    Chopra, Soeb
    Debussche, Xavier
    DIABETES, 2007, 56 : A589 - A589
  • [40] Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial
    Muskiet, M. H. A.
    Bunck, M. C.
    Heine, R. J.
    Corner, A.
    Yki-Jarvinen, H.
    Eliasson, B.
    Joles, J. A.
    Diamant, M.
    Tonneijck, L.
    van Raalte, D. H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 153 : 14 - 22
12345